NOTCH1 drives tumor plasticity and metastasis in hepatocellular carcinoma

  1. Katherine E. Lindblad
  2. Romain Donne
  3. Ian Liebling
  4. Erin Bresnahan
  5. Marina Barcena-Varela
  6. Anthony Lozano
  7. Eric Park
  8. Bruno Giotti
  9. Olivia Burn
  10. Maria I. Fiel
  11. Clara Alsinet
  12. Satdarshan P. Monga
  13. Ruidong Xue
  14. Jose Javier Bravo-Cordero
  15. Alexander M. Tsankov
  16. Amaia Lujambio
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background & Aims

Liver cancer, the third leading cause of cancer-related mortality worldwide, has two main subtypes: hepatocellular carcinoma (HCC), accounting the majority of the cases, and cholangiocarcinoma (CAA). Notch pathway primarily regulates the intrahepatic development of bile ducts, which are lined with cholangiocytes, but it can also be upregulated in 1/3 of HCCs. To better understand the role of NOTCH1 in HCC, we developed a novel mouse model driven by activated Notch1 intracellular domain (NICD1) and MYC overexpression in hepatocytes.

Methods

Using the hydrodynamic tail-vein injection method for establishing primary liver tumors, we generated a novel murine model of liver cancer harboring MYC overexpression and NOTCH1 activation. We characterized this model histopathologically as well as transcriptomically, utilizing both bulk and single cell RNA-sequencing. We also performed functional experiments using monoclonal antibodies.

Results

MYC;NICD1 tumors displayed a combined HCC-CCA phenotype with temporal plasticity. At early time-points, histology was predominantly “cholangiocellular”, which then progressed to mainly “hepatocellular”. The “hepatocellular” component was enriched in mesenchymal genes and gave rise to lung metastasis. Metastatic cells were enriched in the TGFB and VEGF pathways and their inhibition significantly reduced the metastatic burden.

Conclusions

Our novel mouse model uncovered NOTCH1 as a driver of temporal plasticity and metastasis in HCC, the latter of which is, in part, mediated by angiogenesis and TGFß pathways.

Impact and Implications

This study develops a novel murine model of NOTCH1-driven liver cancer, an understudied oncogene in HCC. Using this model, we show that NOTCH1 drives plasticity in HCC and metastasis to the lungs that can be therapeutically targeted through inhibition of VEGF and TGFß pathways.

Highlights

  • NOTCH1 activation in combination with MYC overexpression drives combined HCC-CCA.

  • NOTCH1 activation in hepatocytes drives temporal plasticity.

  • NOTCH1 activation drives metastasis of HCC cells to the lungs, but not of CCA cells.

  • Angiogenesis and TGFß pathways mediate NOTCH1-induced lung metastasis.

Article activity feed

  1. Version published to 10.1101/2024.10.23.619856 on bioRxiv